Litcius/Paper detail

N-acetyl-lysyltyrosylcysteine amide, a novel systems pharmacology agent, reduces bronchopulmonary dysplasia in hyperoxic neonatal rat pups

Ru‐Jeng Teng, Xigang Jing, Dustin P. Martin, Neil Hogg, Aaron Haefke, Girija G. Konduri, Billy W. Day, Stephen Naylor, Kirkwood A. Pritchard

2021Free Radical Biology and Medicine20 citationsDOIOpen Access PDF

Topics & Concepts

HMGB1Bronchopulmonary dysplasiaOxidative stressHyperoxiaMyeloperoxidaseBiologyChemistryInflammationPharmacologyEndocrinologyInternal medicineImmunologyLungMedicinePregnancyGestational ageGeneticsNeonatal Respiratory Health ResearchNeuroscience of respiration and sleepChronic Obstructive Pulmonary Disease (COPD) Research
N-acetyl-lysyltyrosylcysteine amide, a novel systems pharmacology agent, reduces bronchopulmonary dysplasia in hyperoxic neonatal rat pups | Litcius